Site Search:

Literature for Health Professionals

Wilms Tumor

Review

Green DM, D'Angio GJ, Beckwith JB, et al. Wilms Tumor. CA Cancer J Clin. 1996 Jan-Feb 46(1):46-63.

Grundy P, Perlman E, Rosen N, et al. Current issues in Wilms tumor management. Curr Probl Cancer. 2005 Sep-Oct 29(5):221-60.

Grundy PE , Breslow NE , Li S, et al. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group. J Clin Oncol. 2005, 23 (29): 7312-21.

Pizzo PA, Poplack DG. Principles and Practice of Pediatric Oncology. Philadelphia, J. B. Lippincott Co., 1997, 761-797.

Dome JS, Cotton CA , Perlman EJ, et al. Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study. J Clin Oncol. 2006 May 20;24(15):2352-8.

Syndromes

DeBaun MR, Tucker MA. Risk of cancer during the first four years of life in children from The Beckwith-Wiedemann Syndrome Registry. J Pediatr. 1998, 132 (3 Pt 1): 398-400.

Porteus MH, Narkool P, Neuberg D, et al. Characteristics and outcome of children with Beckwith-Wiedemann syndrome and Wilms' tumor: a report from the National Wilms Tumor Study Group. J Clin Oncol. 2000, 18 (10): 2026-31.

Hoyme HE, Seaver LH, Jones KL, et al. Isolated hemihyperplasia (hemihypertrophy): report of a prospective multicenter study of the incidence of neoplasia and review. Am J Med Genet. 1998, 79 (4): 274-8.

Abraham P. What is the risk of cancer in a child with hemihypertrophy? Arch Dis Child. 2005 Dec 90(12):1312-3.

Green DM, Breslow NE , Beckwith JB, et al. Screening of children with hemihypertrophy, aniridia, and Beckwith-Wiedemann syndrome in patients with Wilms tumor: a report from the National Wilms Tumor Study. Med Pediatr Oncol. 1993, 21 (3): 188-92.

Muto R, Yamamori S, Ohashi H, et al. Prediction by FISH analysis of the occurrence of Wilms tumor in aniridia patients. Am J Med Genet. 2002, 108 (4): 285-9.

Breslow NE, Norris R, Norkool PA, et al. Characteristics and outcomes of children with the Wilms tumor-Aniridia syndrome: a report from the National Wilms Tumor Study Group. J Clin Oncol. 2003, 21 (24): 4579-85.

Breslow NE, Takashima JR, Ritchey ML, et al. Renal failure in the Denys-Drash and Wilms' tumor-aniridia syndromes. Cancer Res. 2000, 60 (15): 4030-2.

Merguerian PA. Pediatric genitourinary tumors. Cur Opin Oncol. 2003 May 15(3):222-6.

Coppes MJ, Huff V, Pelletier J. Denys-Drash syndrome: relating a clinical disorder to genetic alterations in the tumor suppressor gene WT1. J Pediatr. 1993, 123 (5): 673-8.

Staging

National Wilms' Tumor Study Committee. Wilms' tumor: status report, 1990. J Clin Oncol. 1991, 9 (5): 877-87.

D'Angio GJ, Breslow N, Beckwith JB, et al. Treatment of Wilms' tumor. Results of the Third National Wilms' Tumor Study. Cancer. 1989, 64 (2): 349-60.

Ritchey ML, Coppes MJ. The management of synchronous bilateral Wilms tumor. Hematol Oncol Clin North Am. 1995, 9 (6): 1303-15.

Ritchey ML, Pringle KC, Breslow NE, et al. Management and outcome of inoperable Wilms tumor. A report of National Wilms Tumor Study-3. Ann Surg. 1994, 220 (5): 683-90 .

Treatment

Green DM. The treatment of stages I-IV favorable histology Wilms' tumor. J Clin Oncol. 2004, 22 (8): 1366-72.

Green DM, Breslow NE , Beckwith JB, et al. Treatment with nephrectomy only for small, stage I/favorable histology Wilms' tumor: a report from the National Wilms' Tumor Study Group. J Clin Oncol. 2001, 19:3719-24.

Green D.M, et al. Treatment of children with stages II to IV anaplastic Wilms' tumor: a report from the National Wilms' Tumor Study Group. J. Clin. Oncol. 1994, 12:2126-2131.

Ritchey ML. Renal sparing surgery for Wilms tumor. J Urol. 2005, 174 (4 Pt 1): 1172-3.

Biology

Brown KW, Malik KT. The molecular biology of Wilms tumour. Expert Rev Mol Med. 2001 May 14 2001:1-16.

Ritchey ML. Recent progress in the biology and treatment of Wilms' tumor. Curr Urol Rep. 2001 Apr 2(2):127-31.

Jones KP, Grundy PE , Coppes MJ. Recent advances in the genetics of childhood renal cancers: a report of the 3rd International Conference on the molecular and clinical genetics of childhood renal tumors, together with the Mitchell Ross symposium on anaplastic and other high risk embryonal tumors of childhood, 8-10th April 1999, Wistar Institute, Philadelphia, PA.Med Pediatr Oncol. 2000, 35:126-30.

Rhabdoid tumor

Waldron PE , Rodgers BM, Kelly MD, et al. Successful treatment of a patient with stage IV rhabdoid tumor of the kidney: case report and review. J Pediatr Hematol Oncol. 1999, 21 (1): 53-7.

Wagner L, Hill DA, Fuller C, et al. Treatment of metastatic rhabdoid tumor of the kidney. J Pediatr Hematol Oncol. 2002, 24 (5): 385-8.

Tomlinson GE, Breslow NE , Dome J, et al. Rhabdoid tumor of the kidney in the National Wilms' Tumor Study: age at diagnosis as a prognostic factor. J Clin Oncol. 2005, 23 (30): 7641-5.

Pizzo PA, Poplack DG. Principles and Practice of Pediatric Oncology. Philadelphia, J. B. Lippincott Co., 1997, 761-797.

Hoot AC, Russo P, Judkins AR , et al. Immunohistochemical analysis of hSNF5/INI1 distinguishes renal and extra-renal malignant rhabdoid tumors from other pediatric soft tissue tumors. Am J Surg Pathol. 2004, 28:1485-1491.

Wick M.R, Ritter J.H, Dehner L.P. Malignant rhabdoid tumors: a clinicopathologic review and conceptual discussion. Semin. Diagn. Pathol. 1995, 12:233-248.

Dome J.S, Hill D.A, McCarville M. Rhabdoid tumor of the kidney. eMedicine Journal 3. Boston Medical Publishing, 2002.

Kodet R, et al. Rhabdoid tumors of soft tissues: a clinicopathologic study of 26 cases enrolled on the Intergroup Rhabdomyosarcoma Study. Hum Pathol. 1991, 22:674-684.

Renal Cell Carcinoma

Fyfe G, Fisher RI, Rosenberg SA, et al. Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy. J Clin Oncol. 1995, 13 (3): 688-96.

Pizzo PA, Poplack DG. Principles and Practice of Pediatric Oncology. Philadelphia, J. B. Lippincott Co., 1997, 761-797.

Bruder E, Passera O, Harms D. Morphologic and molecular characterization of renal cell carcinoma in children and young adults. Am J Surg Pathol. 2004, 28:1117-1132.

Swartz MA, Karth J, Schneider DT, et al. Renal medullary carcinoma: clinical, pathologic, immunohistochemical, and genetic analysis with pathogenetic implications. Urology. 2002, 60:1083-1089.

Davis CJJ, Mostofi FK, Sesterhenn IA. Renal medullary carcinoma. The seventh sickle cell nephropathy Am.J.Surg.Pathol. 1995, 19:1-11.

Indolfi P, et al. Renal cell carcinoma in children: a clinicopathologic study. J Clin Oncol. 2003, 21:530-535.

Uchiyama M, et al. Treatment of childhood renal cell carcinoma with lymph node metastasis: two cases and a review of literature. J Surg Oncol. 2000, 75:266-269.

Androulakakis P.A, Polychronopoulou-Androulakaki S, Michael V, et al. Renal cell carcinoma in children under 14 years old: long-term survival. BJU. Int. 1999, 83:654-657.

Carcao M.D, et al. Renal-cell carcinoma in children: A different disorder from its adult counterpart. Medical and Pediatric Oncology. 1998, 31:153-158.

Geller JI, Dome JS. Local lymph node involvement does not predict poor outcome in pediatric renal cell carcinoma. Cancer Chemother Pharmacol. 2004, 101(7):1575-83.

Motzer R.J, et al. Effect of cytokine therapy on survival for patients with advanced renal cell carcinoma. J Clin Oncol. 2000, 18:1928-1935.

Bukowski R.M. Cytokine combinations: therapeutic use in patients with advanced renal cell carcinoma. Semin Oncol. 2000, 27:204-212.

Ficarra V, et al. Prognostic factors in patients with renal cell carcinoma: Retrospective analysis of 675 cases. Eur. Urol. 2002, 41:190-198.

Clear Cell Sarcoma

Seibel NL, Li S, Breslow NE , et al. Effect of duration of treatment on treatment outcome for patients with clear-cell sarcoma of the kidney: a report from the National Wilms' Tumor Study Group. J Clin Oncol. 2004, 22 (3): 468-73.

Argani P, Perlman EJ, Breslow NE , et al. Clear cell sarcoma of the kidney: a review of 351 cases from the National Wilms Tumor Study Group Pathology Center. Am J Surg Pathol. 2000, 24 (1): 4-18.

Pizzo PA, Poplack DG. Principles and Practice of Pediatric Oncology. Philadelphia, J. B. Lippincott Co., 1997, 761-797.

Green D.M, et al. Treatment of children with clear-cell sarcoma of the kidney: a report from the National Wilms' Tumor Study Group. J. Clin. Oncol. 1994,12:2132-2137.

Congenital Mesoblastic Nephroma

Pizzo PA, Poplack DG. Principles and Practice of Pediatric Oncology. Philadelphia, J. B. Lippincott Co., 1997, 761-797.

General After Treatment Effects

Kidney Information

American Academy of Pediatrics Committee on Sports Medicine and Fitness. Medical Conditions Affecting Sports Participation. Pediatrics 2001; 107:1205-1209.

Johnson B, Christensen C, Dirusso S, et al.; A need for reevaluation of sports participation recommendations for children with a solitary kidney. J Urol 2005; 174:686-9

Pregnancy and Fertility Information

Kalapurakal, JA, Peterson, S, Peabody, EM, Thomas, PRM, Green, DM, D'Angio, GJ, Breslow, NE (2004). Pregnancy outcomes after abdominal irradiation that included or excluded the pelvis in childhood Wilms tumor survivors: a report from the National Wilms Tumor Study. Int. J. Radiation Oncology Biol. Phys. 58(5):1364-1368.

Green, DM, Peabody, EM, Nan, B, Peterson, S, Kalapurakal, JA, Breslow, NE (2002). Pregnancy outcome after treatment for Wilms tumor: a report from the National Wilms Tumor Study Group. J Clin Oncol 20:2506-2513.

For more information about these articles, please send an email to iukidney@iupui.edu.